pepinemab,trastuzumab
roche,vaccinex
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'pepinemab', 'vaccinex']
. with vaccinex co-authors will present "phase i study of adoptive t cell therapy following her2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic her2-positive breast cancer" at #sitc22. register here: $vcnx